BR0110871A - Derivados de sulfonamida - Google Patents
Derivados de sulfonamidaInfo
- Publication number
- BR0110871A BR0110871A BR0110871-9A BR0110871A BR0110871A BR 0110871 A BR0110871 A BR 0110871A BR 0110871 A BR0110871 A BR 0110871A BR 0110871 A BR0110871 A BR 0110871A
- Authority
- BR
- Brazil
- Prior art keywords
- sulfonamide derivatives
- psychiatric
- useful
- compound
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
"DERIVADOS DE SULFONAMIDA". A presente invenção refere-se a um composto de fórmula (Ia) ou um sal farmaceuticamente aceitável deste que é útil para o tratamento de condições associadas com hipofunção de glutamato, tal como distúrbios psiquiátricos e neurológicos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20582200P | 2000-05-19 | 2000-05-19 | |
PCT/US2001/011746 WO2001090056A1 (en) | 2000-05-19 | 2001-05-04 | Sulfonamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0110871A true BR0110871A (pt) | 2003-02-11 |
Family
ID=22763775
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0110871-9A BR0110871A (pt) | 2000-05-19 | 2001-05-04 | Derivados de sulfonamida |
Country Status (25)
Country | Link |
---|---|
US (2) | US6720357B2 (pt) |
EP (1) | EP1296944A1 (pt) |
JP (1) | JP2003534315A (pt) |
KR (1) | KR20030007643A (pt) |
CN (1) | CN1429206A (pt) |
AR (1) | AR028590A1 (pt) |
AU (1) | AU2001262936A1 (pt) |
BR (1) | BR0110871A (pt) |
CA (1) | CA2409829A1 (pt) |
CZ (1) | CZ20023796A3 (pt) |
DZ (1) | DZ3344A1 (pt) |
EA (1) | EA004868B1 (pt) |
EC (1) | ECSP014079A (pt) |
HR (1) | HRP20020917A2 (pt) |
HU (1) | HUP0302291A3 (pt) |
IL (1) | IL152154A0 (pt) |
MX (1) | MXPA02010021A (pt) |
NO (1) | NO20025533L (pt) |
NZ (1) | NZ521620A (pt) |
PE (1) | PE20011260A1 (pt) |
PL (1) | PL358184A1 (pt) |
SK (1) | SK16322002A3 (pt) |
SV (1) | SV2002000458A (pt) |
WO (1) | WO2001090056A1 (pt) |
ZA (1) | ZA200208746B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA59384C2 (uk) * | 1996-12-20 | 2003-09-15 | Пфайзер, Інк. | Похідні сульфонамідів та амідів як агоністи простагландину, фармацевтична композиція та способи лікування на їх основі |
GB9702194D0 (en) | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
EP1438036A2 (en) * | 2001-10-12 | 2004-07-21 | Eli Lilly And Company | Use of sulfonamide derivatives as pharmaceuticals compounds |
WO2005013961A1 (en) * | 2003-07-17 | 2005-02-17 | Eli Lilly And Company | Combination therapy for treatment of cognitive disorders or psychoses |
CA2538291A1 (en) * | 2003-09-18 | 2005-03-31 | Merck & Co., Inc. | Substituted sulfonamides |
PL2445883T3 (pl) | 2009-06-26 | 2014-12-31 | Pfizer | Heterocykliczne sulfonamidy, ich zastosowania i kompozycje farmaceutyczne |
KR101569842B1 (ko) | 2009-09-30 | 2015-11-17 | 삼성전자 주식회사 | 텔레비전용 전원공급유닛 및 이를 포함하는 텔레비전 |
WO2011109398A2 (en) | 2010-03-02 | 2011-09-09 | President And Fellows Of Harvard College | Methods and compositions for treatment of angelman syndrome and autism spectrum disorders |
WO2014201411A1 (en) | 2013-06-13 | 2014-12-18 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9702194D0 (en) * | 1997-02-04 | 1997-03-26 | Lilly Co Eli | Sulphonide derivatives |
WO2000006537A1 (en) * | 1998-07-31 | 2000-02-10 | Eli Lilly And Company | N-substituted sulfonamide derivatives |
PE20000943A1 (es) | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de sulfonamida |
JP2002521444A (ja) | 1998-07-31 | 2002-07-16 | イーライ・リリー・アンド・カンパニー | 複素環スルホンアミド誘導体 |
PE20000942A1 (es) | 1998-07-31 | 2000-09-28 | Lilly Co Eli | Derivados de amida, carbamato y urea |
-
2001
- 2001-05-04 EP EP01937173A patent/EP1296944A1/en not_active Withdrawn
- 2001-05-04 US US10/258,054 patent/US6720357B2/en not_active Expired - Fee Related
- 2001-05-04 BR BR0110871-9A patent/BR0110871A/pt not_active IP Right Cessation
- 2001-05-04 CZ CZ20023796A patent/CZ20023796A3/cs unknown
- 2001-05-04 SK SK1632-2002A patent/SK16322002A3/sk unknown
- 2001-05-04 PL PL01358184A patent/PL358184A1/xx not_active Application Discontinuation
- 2001-05-04 AU AU2001262936A patent/AU2001262936A1/en not_active Abandoned
- 2001-05-04 CN CN01809668A patent/CN1429206A/zh active Pending
- 2001-05-04 NZ NZ521620A patent/NZ521620A/en unknown
- 2001-05-04 KR KR1020027015542A patent/KR20030007643A/ko not_active Application Discontinuation
- 2001-05-04 IL IL15215401A patent/IL152154A0/xx unknown
- 2001-05-04 MX MXPA02010021A patent/MXPA02010021A/es unknown
- 2001-05-04 WO PCT/US2001/011746 patent/WO2001090056A1/en not_active Application Discontinuation
- 2001-05-04 CA CA002409829A patent/CA2409829A1/en not_active Abandoned
- 2001-05-04 HU HU0302291A patent/HUP0302291A3/hu unknown
- 2001-05-04 JP JP2001586246A patent/JP2003534315A/ja not_active Withdrawn
- 2001-05-04 DZ DZ013344A patent/DZ3344A1/fr active
- 2001-05-04 EA EA200201232A patent/EA004868B1/ru not_active IP Right Cessation
- 2001-05-18 EC EC2001004079A patent/ECSP014079A/es unknown
- 2001-05-18 SV SV2001000458A patent/SV2002000458A/es not_active Application Discontinuation
- 2001-05-18 PE PE2001000452A patent/PE20011260A1/es not_active Application Discontinuation
- 2001-05-18 AR ARP010102376A patent/AR028590A1/es unknown
-
2002
- 2002-10-29 ZA ZA200208746A patent/ZA200208746B/en unknown
- 2002-11-18 NO NO20025533A patent/NO20025533L/no not_active Application Discontinuation
- 2002-11-19 HR HR20020917A patent/HRP20020917A2/hr not_active Application Discontinuation
-
2003
- 2003-12-24 US US10/746,164 patent/US6803484B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EA200201232A1 (ru) | 2003-04-24 |
IL152154A0 (en) | 2003-05-29 |
US6803484B2 (en) | 2004-10-12 |
NO20025533D0 (no) | 2002-11-18 |
SK16322002A3 (sk) | 2003-05-02 |
NO20025533L (no) | 2003-01-20 |
EA004868B1 (ru) | 2004-08-26 |
PL358184A1 (en) | 2004-08-09 |
CA2409829A1 (en) | 2001-11-29 |
EP1296944A1 (en) | 2003-04-02 |
CZ20023796A3 (cs) | 2003-04-16 |
JP2003534315A (ja) | 2003-11-18 |
SV2002000458A (es) | 2002-10-24 |
WO2001090056A1 (en) | 2001-11-29 |
MXPA02010021A (es) | 2003-02-12 |
AR028590A1 (es) | 2003-05-14 |
US20040143020A1 (en) | 2004-07-22 |
HUP0302291A3 (en) | 2006-11-28 |
KR20030007643A (ko) | 2003-01-23 |
CN1429206A (zh) | 2003-07-09 |
US6720357B2 (en) | 2004-04-13 |
ECSP014079A (es) | 2002-02-25 |
US20030233015A1 (en) | 2003-12-18 |
DZ3344A1 (fr) | 2001-11-29 |
HUP0302291A2 (hu) | 2003-11-28 |
NZ521620A (en) | 2004-08-27 |
ZA200208746B (en) | 2004-02-10 |
PE20011260A1 (es) | 2001-12-11 |
AU2001262936A1 (en) | 2001-12-03 |
HRP20020917A2 (en) | 2004-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0311494A (pt) | Novos indóis substituìdos | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
FI950309A (fi) | Proliiniamidijohdannaisia | |
NO20032208D0 (no) | Benzodiazepinderivater som GABA A reseptormodulatorer | |
BR0012697A (pt) | Inibidores da diferenciação de th2 | |
BR0215151A (pt) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
BR0113389A (pt) | Compostos que inibem a atividade do fator xa | |
DE60104697D1 (de) | Sulfonamid-derivate | |
BR0113590A (pt) | 7-oxo-piridopirimidinas | |
BR0110871A (pt) | Derivados de sulfonamida | |
NO20001781L (no) | 3-amino-3-arylpropan-1-og lignende-derivater, deres fremstilling og anvendelse | |
BR0215067A (pt) | Piridoquinoxalinas antivirais | |
BR0110874A (pt) | Derivados de sulfonamida | |
SE0101082D0 (sv) | Novel use | |
DE69823240D1 (de) | Immunmodulierende arzneimittelzusammenstellung | |
BR0316751A (pt) | Análogos de gabapentina para fibromialgia e outros distúrbios relacionados | |
HN2001000119A (es) | S-metil-dihidro -ziprasidona para el tratamiento de trastornos psiquiatricos y oculares. | |
BR0207307A (pt) | Inibidores de glyt-1 | |
PT1049672E (pt) | Derivados de azetidinocarboxamida para o tratamento de disturbios do snc | |
ES2181387T3 (es) | Derivados de azetidinocarboxamida para el tratamiento de trastornos del sistema nervioso central. | |
BR0200476A (pt) | Bifenilsulfonamidas tricìclicas como inibidores de metaloproteinase da matriz | |
EP1210948A4 (en) | DRUGS FOR NERVOUS DISEASES | |
EP1393727A4 (en) | MEANS FOR THE TREATMENT OF MYELOPATHY | |
CR6828A (es) | S-metil-dihidro-ziprasidona para el tratamiento de trastornos psiquiatricos y oculares |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009. |